Politics U.S. to see higher generic drug prices on tariffs: Indian pharma CEO Finance News Jul 24, 2026 A visitor walks next to the logo of the Indian multinational pharmaceutical company Dr. Reddy's Laboratories during… Read More...
Politics Eli Lilly will file for approval of retatrutide obesity drug in 2027 Finance News Jul 23, 2026 The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025.Mike Blake | ReutersEli… Read More...
Politics Novo Nordisk sues Eli Lilly over GLP-1 ads Finance News Jul 21, 2026 Photo illustration of a group of weight loss medications on a white background.Ucg | Universal Images Group | Getty… Read More...
Politics Market for psychedelic drugs to treat mental health gets a buy signal Finance News Jul 19, 2026 Psilocybin mushrooms stand ready for harvest in a humidified "fruiting chamber." John Moore | Getty ImagesThursday's… Read More...
Politics Ozempic for cats? GLP-1 weight-loss drugs are coming for your fat pet Finance News Jul 17, 2026 A beautiful, but over weight Maine Coon Cat gets measured around the belly by a vet.Ryersonclark | E+ | Getty… Read More...
Earnings UnitedHealth Group (UNH) earnings Q2 2026 Finance News Jul 16, 2026 UnitedHealth Group on Thursday posted second-quarter earnings that blew past estimates and raised its full-year… Read More...
Business GLP-1 implant from Vivani Medical aims to help patients stay on treatment Finance News Jul 11, 2026 Michael Siluk | UCG | Universal Images Group | Getty ImagesLosing weight with GLP-1 drugs is only half the battle.… Read More...
Politics AstraZeneca’s trial flop raises bigger questions around its pipeline Finance News Jul 10, 2026 AstraZeneca's failed late-stage trial for Wainua was never expected to have a major financial impact on the… Read More...
Politics Abivax $920 million cash haul lets it prepare for U.S. launch: CEO Finance News Jul 10, 2026 Abivax's latest funding round allows the biotech to move toward a U.S. launch of its bowel disease drug without… Read More...
Politics AstraZeneca stock dives 9% after heart drug trial misses target Finance News Jul 9, 2026 Shares of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease failed to meet its… Read More...